Longidaza®
International nonproprietary name
Bovhyaluronidase azoximer*, **
Description
The original enzyme medicine for complex treatment of diseases accompanied by connective tissue hyperplasia (adhesions, cicatricial processes, various types of fibrosis).
Therapeutic areas
Gynecology, urology, dermatology and venereology, pulmonology and phthisiology, surgery, esthetic medicine, and rheumatology.
* The World Health Organization (WHO) assigned an international nonproprietary name (INN) to the Russian product Longidaza® in 2015.
** WHO Drug Information, Vol. 29, No. 3, 2015, L. 74
Product forms
Suppositories
Instruction (PDF)
Lyophilized for solution for injection
Instruction (PDF)THERE ARE CONTRAINDICATIONS. CONSULT A SPECIALIST BEFORE USE
